A cost minimisation analysis of NOACs compared to warfarin to attain therapeutic anticoagulation amongst AF patients, pre- and post-cardioversion

Show simple item record

dc.contributor.author O'Shea, M.
dc.contributor.author Murphy, Aileen
dc.contributor.author Kirby, Ann
dc.contributor.author Allen, G.
dc.contributor.author O'Shea, S.
dc.contributor.author Curtin, R.
dc.date.accessioned 2018-02-09T12:16:20Z
dc.date.available 2018-02-09T12:16:20Z
dc.date.issued 2016-11
dc.identifier.citation O'Shea, M., Murphy, A., Kirby, A., Allen, G., O'Shea, S. and Curtin, R. (2016) 'A cost minimisation analysis of NOACs compared to warfarin to attain therapeutic anticoagulation amongst AF patients, pre- and post-cardioversion', Irish Medical Journal, 109(10), 480 (7pp). en
dc.identifier.volume 109 en
dc.identifier.issued 10 en
dc.identifier.startpage 1 en
dc.identifier.endpage 7 en
dc.identifier.issn 0332-3102
dc.identifier.uri http://hdl.handle.net/10468/5432
dc.description.abstract Atrial fibrillation can be managed with anticoagulation and restoration of normal sinus rhythm using direct current cardioversion (DCCV). To reduce the risk of thromboembolism anticoagulation pre-and-post DCCV is recommended. This study investigates the cost effectiveness of using NOACs compared to warfarin to attain therapeutic anticoagulation amongst AF patients pre-and-post DCCV. Propensity score matching revealed no statistically significant difference in outcomes from using NOACs and Warfarin. A cost minimisation study was performed; demonstrating a cost differential of €209 between those administered NOACs and warfarin pre and post DCCV. This study demonstrates how using NOACs compared to warfarin to attain therapeutic anticoagulation amongst AF patients preand-post DCCV is cost effective. en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher Irish Medical Organisation en
dc.relation.uri http://imj.ie/novemberdecember-2016-vol-109-no-10/
dc.rights © 2016, Irish Medical Journal. All rights reserved. en
dc.subject Anticoagulants en
dc.subject Medicines en
dc.subject Heart disease en
dc.title A cost minimisation analysis of NOACs compared to warfarin to attain therapeutic anticoagulation amongst AF patients, pre- and post-cardioversion en
dc.type Article (peer-reviewed) en
dc.internal.authorcontactother Aileen Murphy, Economics, University College Cork, Cork, Ireland. +353-21-490-3000 Email: aileen.murphy@ucc.ie en
dc.internal.availability Full text available en
dc.date.updated 2018-01-26T12:39:13Z
dc.description.version Published Version en
dc.internal.rssid 376546654
dc.description.status Peer reviewed en
dc.identifier.journaltitle Irish Medical Journal en
dc.internal.copyrightchecked Yes en
dc.internal.licenseacceptance Yes en
dc.internal.IRISemailaddress aileen.murphy@ucc.ie en


Files in this item

This item appears in the following Collection(s)

Show simple item record

This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement